Whalegun
Lobbying

Purdue Pharma's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $200K. Its first report covers Q4 2022; the issues it reports most are Bankruptcy and Health Issues.

Purdue Pharma

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$200K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Purdue Pharma lobbying by quarter
Purdue Pharma lobbying by quarter
QuarterAmountReports
Q4 2022$150K2
Q1 2023$150K2
Q2 2023$150K2
Q3 2023$150K2
Q4 2023$150K2
Q1 2024$150K2
Q2 2024$150K2
Q3 2024$150K2
Q4 2024$150K2
Q1 2025$150K2
Q2 2025$150K2
Q3 2025$150K2
Q4 2025$150K2
Q1 2026$50K1
Q2 2026$01
Q3 2026$00

By issue

  • Bankruptcy$775K · 22 reports
  • Health issues$775K · 22 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports

Firms it paid

Firm
In-housePurdue Pharma$1.4M15 quarters
Capitol Hill Consulting Group$650K13 quarters

Former officials lobbying for it

Former position
BRIAN SUTTERStaff Dir., W&M Health Subcommittee, Chairman Dave Camp April, 2013 - Dec. 2014; Professional Staff, W&M Health Subcommittee, Chairman Dave Camp, Jan. 2011 - April 2013;Leg Dir., Rep. Dave Camp, May '08 - Jan.,'11 Leg Asst.Rep Camp, Feb '03-May'08;Q4 2025
CHRISTOPHER DAVISStaff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011.Q4 2025
EMILY ELIZABETH WILKINSON-HOLLANDStaff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19)Q4 2025

Lobbying reports

Filed by
07/16for Q2In-houseUnder $5,000
04/20for Q1In-house$50K
01/20for Q4 2025Capitol Hill Consulting Group$50K
01/19for Q4 2025In-house$100K
25/10/20for Q3 2025In-house$100K
25/10/19for Q3 2025Capitol Hill Consulting Group$50K
25/07/21for Q2 2025Capitol Hill Consulting Group$50K
25/07/21for Q2 2025Capitol Hill Consulting Group$50K
25/07/18for Q2 2025In-house$100K
25/04/21for Q1 2025Capitol Hill Consulting Group$50K
25/04/20for Q1 2025In-house$100K
25/01/21for Q4 2024In-house$100K
25/01/20for Q4 2024Capitol Hill Consulting Group$50K
24/10/20for Q3 2024Capitol Hill Consulting Group$50K
24/10/19for Q3 2024In-house$100K
24/09/17for Q2 2024Capitol Hill Consulting Group$50K
24/07/14for Q2 2024In-house$100K
24/04/21for Q1 2024Capitol Hill Consulting Group$50K
24/04/19for Q1 2024In-house$100K
24/01/19for Q4 2023Capitol Hill Consulting Group$50K